Average cost of drugs for extensively drug-resistant tuberculosis in Rwanda
Rwanda: Average cost of drugs for extensively drug-resistant tuberculosis was 1,483 constant 2022 US$ in 2024. ▼ Falling
Average cost of drugs for extensively drug-resistant tuberculosis in Rwanda, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
In 2024, average cost of drugs for extensively drug-resistant tuberculosis in Rwanda stood at 1,483 constant 2022 US$. That is the lowest value across all 8 years on record.
The figure is down 81.9% over ten years.
That places Rwanda 35th out of 56 countries with data for 2024, putting it in the middle of the range.
Average cost of drugs for extensively drug-resistant tuberculosis in Rwanda, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 8,181 constant 2022 US$ | — |
| 2018 | 4,473 constant 2022 US$ | -45.3% |
| 2019 | 4,286 constant 2022 US$ | -4.2% |
| 2020 | 4,286 constant 2022 US$ | +0.0% |
| 2021 | 4,287 constant 2022 US$ | +0.0% |
| 2022 | 3,812 constant 2022 US$ | -11.1% |
| 2023 | 1,483 constant 2022 US$ | -61.1% |
| 2024 | 1,483 constant 2022 US$ | +0.0% |
Rwanda compared with similar countries
- Rwanda's 1,483 constant 2022 US$ is below the median for low income countries, which is 1,709 constant 2022 US$, 87% of the median. (9 countries reporting)
- Rwanda's 1,483 constant 2022 US$ is below the median for Sub-Saharan Africa, which is 1,500 constant 2022 US$, 99% of the median. (20 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 5,647 constant 2022 US$ | 4,286 constant 2022 US$ | 8,181 constant 2022 US$ | 3 |
| 2020s | 3,070 constant 2022 US$ | 1,483 constant 2022 US$ | 4,287 constant 2022 US$ | 5 |
Countries ranked near Rwanda
More reference data data for Rwanda
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.2282 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 0.9517 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 1.38 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.1223 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 1.38 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 0.7651 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 0.9517 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 4.27 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 6.98 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 0.666 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Rwanda?
- Average cost of drugs for extensively drug-resistant tuberculosis in Rwanda was 1,483 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Rwanda?
- The highest recorded value was 8,181 constant 2022 US$ in 2017.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Rwanda?
- The lowest recorded value was 1,483 constant 2022 US$ in 2023.
- How does Rwanda rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Rwanda ranks 35th out of 56 countries with data for 2024.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Rwanda?
- Over the last ten years it is down 81.9%. The long-run trend across the full record is falling.
- Where does this Rwanda data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.